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THERE IS EVIDENCE suggesting that transplantation of the pancreas is the 
only approach to a curative treatment of type 
I diabetes.1 - 3 The results of this surgical 
method improved during the last years with 
the new agent cyclosporine (Cs) and better 
patient management. In 1982 the one-year-
survival-rate of pancreas grafts was about 
20% worldwide, whereas in 1984 it had risen 
to 38%.4 In spite of this improvement, pan-
creas transplantation is still less successful 
than transplantation of other organs. One 
major reason for this fact is the difficulty in 
optimal handling of exocrine secretion. 
Since 1979 the Munich group has been 
using prolamine (Ethibloc, Ethicon) in a con-
secutive series of 56 patients. Despite occlu-
sion of the duct, a high incidence of pancreatic 
fistulas occurred, implicating the risk of a 
secondary bacterial contamination. 
By modifying our surgical technique5 to a 
strictly intraperitoneal placement of the pan-
creas graft, we wanted to know whether the 
resorption capacity of the peritoneum would 
provide a reduction of the incidence of fistu-
las. 
PATIENTS AND METHODS 
Fifty-two of those 56 patients received a pancreas and a 
kidney graft simultaneously. In these 52 patients we 
evaluated fistula incidence, frequency of reintervention, 
and graft loss rate secondary to an infected fistula. 
According to the different surgical techniques there are 
two groups: group 1 (n = 25), in which the segmental 
pancreas graft was placed partially extra-and intraperito-
neally6; and group 2 (n = 27), in which the pancreas graft 
was placed strictly intraperitoneal^ along the ascending 
colon. The peritoneal cavity was continuously irrigated 
with saline solution over the first postoperative days. 
RESULTS 
The incidence of fistulas in group 1 was 
52% compared to 44% in group 2. The rate of 
secondary bacterial contamination of a fistula 
with subsequent surgical reinterventions 
showed no significant difference betweeen 
both groups (2 v 2.5). In five patients in group 
1 the rescue of an infected fistula failed, 
compared to two cases in group 2. 
DISCUSSION 
Our working hypothesis claimed that reab-
sorption of residual exocrine secretion by the 
peritoneum would reduce the incidence of 
fistulas. This could not be confirmed, because 
neither the fistula incidence rate nor the re-
operating rate were statistically different. 
Specific and specific defense mechanisms of 
the peritoneum seem to have a positive effect 
against secondary infection of a fistula. Graft 
loss due to a fistula occurred in only 8% of 
patients treated with the modified technique 
(group 2) compared to 20% of the patients in 
group 1. 
The improvement of graft survival rate 
(15% difference between group 1 and group 2) 
is probably based on defense mechanisms of 
the peritoneum. Therefore, we will continue to 
use the strictly intraperitoneal placement of 
duct-occluded pancreas grafts. 
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